Senior Communications Manager
Brian Pandya Discusses Supreme Court Ruling to Uphold Patent Procedures
Brian H. Pandya, a partner in Wiley Rein’s Intellectual Property and Litigation practices, was quoted in The Wall Street Journal’s coverage of the Supreme Court of the United States’ decision to uphold a 2011 law that created new procedures for challenging patents in front of the U.S. Patent & Trademark Office’s (USPTO) Patent Trial & Appeal Board (PTAB).
The Court’s June 20 ruling is generally viewed as a boost for technology companies, as well as generic drug makers and hedge funds, that have used the new procedures to challenge patents, according to the Journal article.
Mr. Pandya told the Journal that this PTAB process has also become popular with generic drug companies and hedge funds, which have sought to challenge patents held by brand-name drug makers. “Today’s decision is going to further cement the popularity” of the PTAB proceedings, he said.
The article can be found here (subscription required).